- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website
Versican Plus DHPPi/L4 : EPAR - Summary for the public
English (EN) (81.94 KB - PDF)
български (BG) (93.36 KB - PDF)
español (ES) (81.97 KB - PDF)
čeština (CS) (93.99 KB - PDF)
dansk (DA) (83.34 KB - PDF)
Deutsch (DE) (82.76 KB - PDF)
eesti keel (ET) (82.18 KB - PDF)
ελληνικά (EL) (93.76 KB - PDF)
français (FR) (82.44 KB - PDF)
hrvatski (HR) (92.27 KB - PDF)
íslenska (IS) (83.29 KB - PDF)
Gaeilge (GA) (83.57 KB - PDF)
italiano (IT) (82.29 KB - PDF)
latviešu valoda (LV) (94.29 KB - PDF)
lietuvių kalba (LT) (94.03 KB - PDF)
magyar (HU) (94.15 KB - PDF)
Malti (MT) (95.95 KB - PDF)
Nederlands (NL) (82.05 KB - PDF)
norsk (NO) (82 KB - PDF)
polski (PL) (95.62 KB - PDF)
português (PT) (83.01 KB - PDF)
română (RO) (94.17 KB - PDF)
slovenčina (SK) (94.08 KB - PDF)
slovenščina (SL) (82.27 KB - PDF)
Suomi (FI) (81.54 KB - PDF)
svenska (SV) (82.05 KB - PDF)
Product information
Versican Plus DHPPi/L4 : EPAR - Product Information
English (EN) (81.49 KB - PDF)
български (BG) (91.78 KB - PDF)
español (ES) (81.51 KB - PDF)
čeština (CS) (92.48 KB - PDF)
dansk (DA) (82.05 KB - PDF)
Deutsch (DE) (81.72 KB - PDF)
eesti keel (ET) (81.22 KB - PDF)
ελληνικά (EL) (91.79 KB - PDF)
français (FR) (81.63 KB - PDF)
hrvatski (HR) (91.56 KB - PDF)
íslenska (IS) (81.52 KB - PDF)
Gaeilge (GA) (81.36 KB - PDF)
italiano (IT) (81.76 KB - PDF)
latviešu valoda (LV) (92.14 KB - PDF)
lietuvių kalba (LT) (92.19 KB - PDF)
magyar (HU) (92.76 KB - PDF)
Malti (MT) (93.86 KB - PDF)
Nederlands (NL) (81.15 KB - PDF)
norsk (NO) (81.52 KB - PDF)
polski (PL) (93.22 KB - PDF)
português (PT) (82.53 KB - PDF)
română (RO) (91.73 KB - PDF)
slovenčina (SK) (81.75 KB - PDF)
slovenščina (SL) (81.76 KB - PDF)
Suomi (FI) (81.11 KB - PDF)
svenska (SV) (81.47 KB - PDF)
Versican Plus DHPPi/L4 : EPAR - All Authorised presentations
English (EN) (81.94 KB - PDF)
български (BG) (93.36 KB - PDF)
español (ES) (81.97 KB - PDF)
čeština (CS) (93.99 KB - PDF)
dansk (DA) (83.34 KB - PDF)
Deutsch (DE) (82.76 KB - PDF)
eesti keel (ET) (82.18 KB - PDF)
ελληνικά (EL) (93.76 KB - PDF)
français (FR) (82.44 KB - PDF)
hrvatski (HR) (92.27 KB - PDF)
íslenska (IS) (83.29 KB - PDF)
Gaeilge (GA) (83.57 KB - PDF)
italiano (IT) (82.29 KB - PDF)
latviešu valoda (LV) (94.29 KB - PDF)
lietuvių kalba (LT) (94.03 KB - PDF)
magyar (HU) (94.15 KB - PDF)
Malti (MT) (95.95 KB - PDF)
Nederlands (NL) (82.05 KB - PDF)
norsk (NO) (82 KB - PDF)
polski (PL) (95.62 KB - PDF)
português (PT) (83.01 KB - PDF)
română (RO) (94.17 KB - PDF)
slovenčina (SK) (94.08 KB - PDF)
slovenščina (SL) (82.27 KB - PDF)
Suomi (FI) (81.54 KB - PDF)
svenska (SV) (82.05 KB - PDF)
Product details
- Name of medicine
- Versican Plus DHPPi/L4
- Active substance
- canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B, canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090, L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091...
- International non-proprietary name (INN) or common name
- live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated
Authorisation details
- EMA product number
- EMEA/V/C/003678
Assessment history
Versican Plus DHPPi/L4 : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (81.94 KB - PDF)